Working… Menu

A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00972426
Recruitment Status : Completed
First Posted : September 7, 2009
Last Update Posted : September 5, 2011
Information provided by (Responsible Party):
Taiwan Otsuka Pharm. Co., Ltd

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2010
Actual Study Completion Date : August 2010